Fresenius Medical Care AG (FMS)
21.30
+0.75
(+3.65%)
USD |
NYSE |
Apr 23, 14:17
Fresenius Medical Care Shareholders Equity (Quarterly): 15.06B for Dec. 31, 2023
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 15.06B |
September 30, 2023 | 14.83B |
June 30, 2023 | 14.70B |
March 31, 2023 | 15.08B |
December 31, 2022 | 15.00B |
September 30, 2022 | 14.79B |
June 30, 2022 | 14.68B |
March 31, 2022 | 14.77B |
December 31, 2021 | 14.38B |
September 30, 2021 | 14.19B |
June 30, 2021 | 13.84B |
March 31, 2021 | 14.07B |
December 31, 2020 | 13.79B |
September 30, 2020 | 13.49B |
June 30, 2020 | 13.64B |
March 31, 2020 | 13.23B |
December 31, 2019 | 13.39B |
September 30, 2019 | 13.43B |
June 30, 2019 | 13.20B |
March 31, 2019 | 13.53B |
December 31, 2018 | 13.45B |
September 30, 2018 | 13.03B |
June 30, 2018 | 12.60B |
March 31, 2018 | 12.25B |
December 31, 2017 | 11.78B |
Date | Value |
---|---|
September 30, 2017 | 11.39B |
June 30, 2017 | 11.05B |
March 31, 2017 | 10.90B |
December 31, 2016 | 10.55B |
September 30, 2016 | 10.59B |
June 30, 2016 | 10.18B |
March 31, 2016 | 10.19B |
December 31, 2015 | 9.887B |
September 30, 2015 | 9.629B |
June 30, 2015 | 9.572B |
March 31, 2015 | 9.551B |
December 31, 2014 | 9.443B |
September 30, 2014 | 9.487B |
June 30, 2014 | 9.382B |
March 31, 2014 | 9.424B |
December 31, 2013 | 9.235B |
September 30, 2013 | 8.855B |
June 30, 2013 | 8.857B |
March 31, 2013 | 9.094B |
December 31, 2012 | 8.942B |
September 30, 2012 | 8.684B |
June 30, 2012 | 8.085B |
March 31, 2012 | 8.337B |
December 31, 2011 | 7.897B |
September 30, 2011 | 7.754B |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
13.20B
Minimum
Jun 2019
15.08B
Maximum
Mar 2023
14.19B
Average
14.19B
Median
Sep 2021
Shareholders Equity (Quarterly) Benchmarks
Biodexa Pharmaceuticals Plc | 5.959M |
NuCana PLC | 18.96M |
Biophytis SA | -4.264M |
TC BioPharm (Holdings) PLC | 3.421M |
DaVita Inc | 1.056B |
Shareholders Equity (Quarterly) Related Metrics
Total Assets (Quarterly) | 37.51B |
Total Liabilities (Quarterly) | 21.12B |
Debt to Equity Ratio | 0.5803 |
Current Ratio | 1.424 |
Net Debt Paydown Yield | -0.29% |